Increased serum visfatin levels in obesity and its association with anthropometric/biochemical parameters, physical inactivity and nutrition

e-SPEN Journal

Volumn 8, Issue 2, 2013, Pages

  Jurdana, Mihaela ^a   Petelin, Ana ^a   černelič Bizjak, MaŠa ^a   Bizjak, Mojca ^a   Biolo, Gianni ^b,c   Jenko PraŽnikar, Zala ^a  

^a UNIVERSITY OF PRIMORSKA   (Slovenia)

^b UNIVERSITY OF TRIESTE   (Italy)

^c UNIVERSITY OF TRIESTE   (Italy)

Author keywords

Nutrition; Obesity; Physical activity; Visfatin

Indexed keywords

ALANINE; AMINO ACID; C REACTIVE PROTEIN; CHOLESTEROL; GLUCOSE; INSULIN; INTERLEUKIN 6; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; OMEGA 3 FATTY ACID; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANTHROPOMETRIC PARAMETERS; ANTHROPOMETRY; ARTICLE; BODY COMPOSITION; BODY MASS; CHEMICAL ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DIETARY INTAKE; ENZYME BLOOD LEVEL; FEMALE; FITNESS; HUMAN; IMMOBILIZATION; MALE; NUTRITION; OBESITY; PREDICTIVE VALUE;

EID: 84875600869     PISSN: None     EISSN: 22128263     Source Type: Journal    
DOI: 10.1016/j.clnme.2013.02.001     Document Type: Article

References (34)

1. Pi-Sunyer F.X. The obesity epidemic: pathophysiology and consequences of obesity. Obes Res 2002, 10(Suppl. 2):97S-104S.
2. Wang Z., Nakayama T. Inflammation, a link between obesity and cardiovascular disease. Mediators Inflamm 2010, published online Aug 5. 10.1155/2010/535918.
3. Samal B., Sun Y., Stearns G., Xie C., Suggs S., McNiece I. Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor. Mol Cell Biol 1994, 14:1431-1437.
4. Fukuhara A., Matsuda M., Nishizawa M., Segawa K., Tanaka M., Kishimoto K., et al. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 2005, 307:426-430.
5. Fukuhara A., Matsuda M., Nishizawa M., Segawa K., Tanaka M., Kishimoto K., et al. Retraction Science 2007, 318:565.
6. Chang Y.H., Chang D.M., Lin K.C., Shin S.J., Lee Y.J. Visfatin in overweight/obesity, type 2 diabetes mellitus, insulin resistance, metabolic syndrome, and cardiovascular diseases: a meta-analysis and systemic review. Diabetes Metab Res Rev 2011, 27:515-527.
7. Pagano C., Pilon C., Olivieri M., Mason P., Fabris R., Serra R., et al. Reduced plasma visfatin/Pre-B cell colony-enhancing factor in obesity is not related to insulin resistance in humans. J Clin Endocrinol Metab 2006, 91:3165-3170.
8. Filippatos T.D., Derdemezis C.S., Kiortsis D.N., Tselepis A.D., Elisaf M.S. Increased plasma levels of visfatin/pre-B cell colony-enhancing factor in overweight and overweight patients with metabolic syndrome. J Endocrinol Invest 2007, 30:323-326.
9. Sun G., Bishop J., Khalili S., Vasdev S., Gill V., Pace D., et al. Serum visfatin concentrations are positively correlated with serum triacylglycerols and down-regulated by overfeeding in healthy young men. Am J Clin Nutr 2007, 85:399-404.
10. Wang P., van Greevenbroek M.M., Bouwman F.G., Brouwers M.C., van der Kallen C.J., Smit E., et al. The circulating PBEF/NAMPT/visfatin level is associated with a beneficial blood lipid profile. Pflugers Arch 2007, 454:971-976.
11. De Luis D.A., Gonzalez Sagrado M., Conde R., Aller R., Izaola O., Romero E. Effect of a hypocaloric diet on serum visfatin in overweight non-diabetic patients. Nutrition 2008, 24:517-521.
12. Choi K.M., Kim J.H., Cho G.J., Baik S.H., Park H.S., Kim S.M. Effect of exercise training on plasma visfatin and eotaxin levels. Eur J Endocrinol 2007, 157:437-442.
13. De Luis D.A., Conde R., Gonzalez Sagrado M., Aller R., Izaola O., Perez Castrillon J.L., et al. Effect of olmesartan vs irbesartan on metabolic parameters and visfatin in hypertensive obese women. Eur Rev Med Pharmacol Sci 2010, 14:759-763.
14. Nederkoorn C., Jansen A. Cue reactivity and regulation of food intake. Eat Behav 2002, 3:61-72.
15. Golob T., Stibilj V., Žlender B., DoberŠek U., Jamnik M., Polak T., et al. Slovenian food composition tables - meat and meat products 2006, University of Ljubljana, Biotechnical faculty.
16. Souici S.W., Fachmann W., Kraut H. Food composition and nutrition tables 2008, MedPharm Scientific Publishers, Stuttgart, Germany. 7th edn.
17. Van Strien T., Frijters J.E.R., Bergers G.P.A., Defares P.B. Dutch eating behaviour questionnaire for assessment of restrained, emotional and external eating behaviour. Int J Eat Disord 1986, 5:295-315.
18. Biering-Sørenson F. Physical measurements as risk indicators for low back trouble over a one-year period. Spine 1984, 9:106-119.
19. Fitness for Health Tamper Finland 2002, At:, [accessed 14.09.12]. http://www.ukkinstituutti.fi.
20. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.
21. Biolo G., Agostini F., Simunic B., Sturma M., Torelli L., Preiser J.C., et al. Positive energy balance is associated with accelerated muscle atrophy and increased erythrocyte glutathione turnover during 5 wk of bed rest. Am J Clin Nutr 2008, 88:950-958.
22. Zahorska-Markiewicz B., Olszanecka-Glinianowicz M., Janowska J., Kocełak P., Semik-Grabarczyk E., Holecki M., et al. serum concentration of visfatin in overweight women. Metab Clin Exp 2007, 56:1131-1134.
23. Smith J., Al-Amri M., Sniderman A., Cianflone K. Visfatin concentration in Asian Indians is correlated with high density lipoprotein cholesterol and apolipoprotein A1. Clin Endocrinol (Oxf) 2006, 65:667-672.
24. Revollo J.R., Körner A., Mills K.F., Satoh A., Wang T., Garten A., et al. Nampt/PBEF/Visfatin regulates insulin secretion in beta cells as a systemic NAD biosynthetic enzyme. Cell Metab 2007, 6:363-375.
25. Araki S., Dobashi K., Kubo K., Kawagoe R., Yamamoto Y., Kawada Y., et al. Plasma visfatin concentration as a surrogate marker for visceral fat accumulation in overweight children. Obesity 2008, 16:384-388.
26. Newgard C.B., An J., Bain J.R., Muehlbauer M.J., Stevens R.D., Lien L.F., et al. A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metabolism 2009, 9:311-326.
27. Filippatos T.D., Tsimihodimos V., Derdemezis C.S., Gazi I.F., Saougos V., Mikhailidis D.P., et al. Increased plasma visfatin concentration is a marker of an atherogenic metabolic profile. Nutr Metab Cardiovasc Dis 2011, published online Oct 1. [Epub ahead of print].
28. De Luis D.A., Gonzalez Sagrado M., Aller R., Conde R., Izaola O. Circulating visfatin in obese non-diabetic patients in relation to caediovascular risk factors, insulin resistance, and adipocytokines: a contradictory piece of the puzzle. Nutrition 2010, 26:1130-1133.
29. Moschen A.R., Kaser A., Enrich B., Mosheimer B., Theurl M., Niederegger H., et al. Visfatin, an adipocytokine with proinflammatory and immunomodulating properties. J Immunol 2007, 178:1748-1758.
30. Ross R., Dagnone D., Jones P.J.H., Smith H., Paddags A., Hudson R., et al. Reduction in obesity and related comorbid conditions after diet-induced weight loss or exercise-induced weight loss in men. A randomized, controlled trial. Ann Intern Med 2000, 133:92-103.
31. Burton P., Smit H.J., Lightowler H.J. The influence of restrained and external eating patterns on overeating. Appetite 2007, 49:191-197.
32. Hajianfar H., Hosseinzadeh M.J., Bahonar A., Mohammad K., Askari G.R., Entezari M.H., et al. The effect of omega-3 on the serum visfatin concentration in patients with type II diabetes. J Res Med Sci 2011, 16:490-495.
33. De Luis D.A., Aller R., Gonzales Sagrado M., Conde R., Izaola O., Castrillon J.L., et al. Serum visfatin concentrations are related to dietary intake in obese patients. Ann Nutr Metab 2010, 57:265-270.
34. North C.J., Venter C.S., Jerling J.C. The effects of dietary fibre on C-reactive protein, an inflammation marker predicting cardiovascular disease. Eur J Clin Nutr 2009, 63:921-933.